Literature DB >> 6781000

Concentrations of Cis(Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord serum, and milk.

L Kirk, A Jørgensen.   

Abstract

A venous blood sample and an umbilical cord blood sample were obtained from five young women treated with the neuroleptic drug, cis(Z)-flupentixol decanoate in Viscoleo (intramuscularly) or flupentixol (orally) at the time of giving birth. In two cases amniotic fluid was also obtained, and from three of the mothers milk and simultaneous blood samples were obtained in the lactation period. Concentrations of the active drug, cis(Z)-flupentixol were measured in serum, amniotic fluid, and milk by radioimmunoassay. It was found that the concentration of the active drug in umbilical cord serum (fetal serum) was lower than that in serum from the mother--the ratio being about 0.24. Thus the amounts of drug reaching the fetus are low, but they cannot be considered unimportant. The concentrations found in milk were about 30% higher than the serum concentrations. However, the amounts of drug administered to the neonate with the milk are very low and, unless the neonate differs considerably from the adult as to sensitivity to or metabolism of this particular drug, they are of no importance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6781000     DOI: 10.1007/BF00433814

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  Distribution of pethidine and chlorpromazine in maternal, foetal and neonatal biological fluids.

Authors:  S E O'Donoghue
Journal:  Nature       Date:  1971-01-08       Impact factor: 49.962

2.  A sensitive and specific radioimmunoassay for cis (Z)-flupenthixol in human serum.

Authors:  A Jørgensen
Journal:  Life Sci       Date:  1978-10-16       Impact factor: 5.037

3.  Chlorpromazine levels in plasma and milk of nursing mothers.

Authors:  D H Wiles; M W Orr; T Kolakowska
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

  3 in total
  9 in total

Review 1.  Antipsychotics and breast-feeding: a review of the literature.

Authors:  T Tényi; G Csábi; M Trixler
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  The quality of lactation studies including antipsychotics.

Authors:  Hazel Hummels; Daphne Bertholee; Douwe van der Meer; Jan Pieter Smit; Bob Wilffert; Peter Ter Horst
Journal:  Eur J Clin Pharmacol       Date:  2016-08-24       Impact factor: 2.953

3.  Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients.

Authors:  I Matheson; J Skjaeraasen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  A guide to the safety of CNS-active agents during breastfeeding.

Authors:  C A Chisholm; J A Kuller
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 5.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 6.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 7.  Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations.

Authors:  G Pons; E Rey; I Matheson
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

8.  Presence of chlorprothixene and its metabolites in breast milk.

Authors:  I Matheson; A Evang; K F Overø; G Syversen
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Zuclopenthixol levels in serum and breast milk.

Authors:  T Aaes-Jørgensen; F Bjørndal; U Bartels
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.